Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Julia Voigt"'
Publikováno v:
Neuroethics. 14:1-3
Emerging neurotechnologies, such as brain-computer interfaces, interact closely with a user’s body by enabling actions controlled with brain activity. This can have a profound impact on the user’s experience of movement, the sense of agency and o
Autor:
Julia Voigt
Publikováno v:
Neuroethics. 14:45-57
The critical aspects of deep brain stimulation (DBS) are usually the focus of the ethical debate about the implantation of electrodes into the brain of patients with Parkinson’s disease (PD). Above all, potential postoperative side effects on perso
Publikováno v:
Journal of the American Chemical Society. 136(29)
Degradable aliphatic polyesters are the cornerstones of nanoparticle (NP)-based therapeutics. In this paradigm, covalent modification of the NP with cell-targeting motifs and dyes can aid in guiding the NP to its destination and gaining visual confir
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America. 111(8)
Nanoparticles (NPs) constitute an important medium for the targeted delivery of cancer therapeutics. Targeting of NPs to a specific cell type is traditionally achieved through the modification of the NP surface with peptides, aptamers, or other motif
Autor:
Andreas Wahl, Tina Zeun, Franziska Götz, Carola Oehme, Julia Voigt, Jennifer Thomas, Maria Machansky
Publikováno v:
HeilberufeScience. 4:37-37
Bereichen die geringste Durchschnittsnote. Das Qualitatskriterium mit der niedrigsten Bewertung war die Durchfuhrung der Kontrakturenprophylaxen (1,93). Ferner waren es Kriterien, wie die Durchfuhrung der Dekubitusprophylaxen (1,86) und die entsprech
Autor:
Sonya Hui, Andrew S Levy, Daniel L Slack, Marcus J Burnstein, Lee Errett, Daniel Bonneau, David Latter, Ori D Rotstein, Steffen-Sebastian Bolz, Darcy Lidington, Julia Voigtlaender-Bolz
Publikováno v:
PLoS ONE, Vol 10, Iss 9, p e0138142 (2015)
We recently identified sphingosine-1-phosphate (S1P) signaling and the cystic fibrosis transmembrane conductance regulator (CFTR) as prominent regulators of myogenic responsiveness in rodent resistance arteries. However, since rodent models frequentl
Externí odkaz:
https://doaj.org/article/0076cb92bd094f78ae1922ad9df7ac14